On 22 September 2022, the Capital Market Supervisory Board Meeting No. 10/2565 passed a resolution approving the proposed amendments to the regulations related to establishment and relocation of offices or branches of business operators in accordance with the Regulatory Guillotine to increase flexibility and streamline processes and operating burdens on the business sector. Essentially, the proposed amendments would: (1) apply the same auto approval principles for the establishment of...
of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27 Notification of the resignation of Chairman of the Audit
Committee, Appointment of Audit Committee, Appointment of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27
, driving higher yield loss; and cost from relocating some product from the old production line to the new one. However, production cost of the new machine has been gradually improving every month. Q2/2018
the issuer’s core business. In any event, the issuer must not operate business in such a way that involves severely illegal business. For example, human trafficking, drug production or smuggling, or
involves severely illegal business. For example, human trafficking, drug smuggling or money laundering etc. Moreover, the issuer must not act in violation or non-compliance with the law, which may cause
stemmed from the decrease in sugar prices and cost of production. Since the 1st quarter of 2017, the Company had been relocating its production lines of sauces and condiments to the new factory, such
, and the office was relocated to support the expansion, resulting in cost of relocating and writing off existing office improvements. There was no such expense in this year, which made the Group's
cost from relocating some product from the old production line to the new one; 4) higher excise tax as well as sugar tax following the Excise Act, B.E. 2560, effective since 16 September 2017; 5) higher
system of new medicines according to the additional standards SET forth by the Food and Drug administration. Therefore, it is necessary to use the capital to proceed the project amount 32,000,000 baht